News
Human Genome Sciences Shares Rose 33% After Meeting Phase 3 Goal For Lupus ...11/2/2009 - Human Genome Sciences (NASDAQ:HGSI) shares rose nearly 33% after the company and GlaxoSmithKline ...
Stocks Running Early (HGSI, VRTX, DNDN, JWN)
Human Genome Sciences (Nasdaq: HGSI) is up 34% in the pre-market after announcing positive results related to its lupus drug. Dendreon Corporation (Nasdaq: ...
xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts November 2, 2009 ...
Human Genome Sciences, Inc. (Nasdaq:HGSI) trading at $25.00 per share on trading volume of 13.83M shares. ROCKVILLE, Md. & LONDON, Nov 02, ...
No comments:
Post a Comment